These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 8809167

  • 1. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H, Katoh S, Sayama S, Murakami K, Nakanishi H, Kajimoto Y, Ueno H, Kawasaki H, Aisaka K, Uchida I.
    J Med Chem; 1996 Sep 13; 39(19):3797-805. PubMed ID: 8809167
    [Abstract] [Full Text] [Related]

  • 2. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives].
    Zhao SY, Huang WL, Zhang HB.
    Yao Xue Xue Bao; 2002 Aug 13; 37(8):621-5. PubMed ID: 12567776
    [Abstract] [Full Text] [Related]

  • 3. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
    Florence X, Sebille S, Tullio Pd, Lebrun P, Pirotte B.
    Bioorg Med Chem; 2009 Nov 15; 17(22):7723-31. PubMed ID: 19822435
    [Abstract] [Full Text] [Related]

  • 4. In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effects.
    Grover GJ, D'Alonzo AJ, Darbenzio RB, Parham CS, Hess TA, Bathala MS.
    J Pharmacol Exp Ther; 2002 Oct 15; 303(1):132-40. PubMed ID: 12235243
    [Abstract] [Full Text] [Related]

  • 5. Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo.
    Hirata Y, Kanada A, Miyai H, Mabuchi Y, Aisaka K.
    Arzneimittelforschung; 1999 Mar 15; 49(3):199-206. PubMed ID: 10219462
    [Abstract] [Full Text] [Related]

  • 6. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
    Cecchetti V, Calderone V, Tabarrini O, Sabatini S, Filipponi E, Testai L, Spogli R, Martinotti E, Fravolini A.
    J Med Chem; 2003 Aug 14; 46(17):3670-9. PubMed ID: 12904071
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 1st communication: effects on myocardium and vasculature.
    Hirata Y, Suzuki Y, Miyai H, Aisaka K.
    Arzneimittelforschung; 2000 Mar 14; 50(3):236-43. PubMed ID: 10758774
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 2nd communication: effects on blood pressure in conscious animals.
    Hirata Y, Suzuki Y, Miyai H, Aisaka K.
    Arzneimittelforschung; 2000 Apr 14; 50(4):333-40. PubMed ID: 10800631
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H, Mimura T, Kagechika K, Ohta M, Kubo H, Kitagawa M.
    Chem Pharm Bull (Tokyo); 1998 Apr 14; 46(4):602-9. PubMed ID: 9579035
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS, Seo HW, Oh JH, Lee BH.
    Arzneimittelforschung; 1998 Oct 14; 48(10):969-78. PubMed ID: 9825113
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
    Bansal R, Kumar D, Carron R, de la Calle C.
    Eur J Med Chem; 2009 Nov 14; 44(11):4441-7. PubMed ID: 19589624
    [Abstract] [Full Text] [Related]

  • 14. Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.
    Atwal KS, Ferrara FN, Ding CZ, Grover GJ, Sleph PG, Dzwonczyk S, Baird AJ, Normandin DE.
    J Med Chem; 1996 Jan 05; 39(1):304-13. PubMed ID: 8568821
    [Abstract] [Full Text] [Related]

  • 15. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB, Giardino EC, Salata JJ, Moore JB, Falotico R.
    J Pharmacol Exp Ther; 1993 Nov 05; 267(2):648-56. PubMed ID: 8246137
    [Abstract] [Full Text] [Related]

  • 16. Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
    Zhang X, Qiu Y, Li X, Bhattacharjee S, Woods M, Kraft P, Lundeen SG, Sui Z.
    Bioorg Med Chem; 2009 Jan 15; 17(2):855-66. PubMed ID: 19101153
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats.
    Yamashita T, Masuda Y, Kawamura N, Fujikura N, Tanaka S.
    Jpn J Pharmacol; 1995 Jun 15; 68(2):145-52. PubMed ID: 7563971
    [Abstract] [Full Text] [Related]

  • 18. Systemic and coronary hemodynamic effects of JTV-506, a novel potassium channel opener, in conscious dogs: comparison with cromakalim and nicorandil.
    Zhang S, Sakai K, Hasuo H, Furuta K, Ureshino H, Shibata O, Sumikawa K.
    Res Commun Mol Pathol Pharmacol; 1999 Jun 15; 105(1-2):115-27. PubMed ID: 10850375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
    Sebille S, Gall D, de Tullio P, Florence X, Lebrun P, Pirotte B.
    J Med Chem; 2006 Jul 27; 49(15):4690-7. PubMed ID: 16854075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.